Called GA4GH Connect, it calls on the alliance's 500-plus members to develop new data sharing standards for use in major international genomic data initiatives.
A life sciences industrial strategy out this week provided long-term guidance for supporting and enhancing growth in the sector in the UK.
Illumina's BaseSpace Variant Interpreter encompasses standards for analysis and interpretation developed under a partnership between the firm and Genomics England.
Core elements of the new program include integrating genomic data into electronic medical records and the establishment of a national genome center.
Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.
Congenica will use the proceeds to establish its presence in the US and China, where it will court not only clinical genetics labs, but specialists, academics, biotech, and pharma.
The company will use the proceeds from the round to invest in sales and marketing efforts for its Sapientia clinical genome analysis platform, as well as for R&D.
Genomics England will use the product to aid scientists and clinicians in 13 National Health Service Genomic Medical Centres with clinical reporting and interpretation.
The center, which is seen as a bellwether for integrating genomic information with EMRs, will use the data to inform efforts to prevent chronic, common diseases.
Genomics plc will analyze de-identified genomics data for the consortium to inform pharmaceutical research and development investment decisions.
In PLOS this week: Mycobacterium abscessus linked to gastric conditions, placental gene expression changes associated with preterm birth, and more.
The Guardian reports that UK universities are looking into ways to reduce labs' reliance on single-use plastics.
People with certain gene variants tend to not like vegetables, particularly bitter ones, CNN reports.
MIT's Technology Review reports on a company's genetic test that gauges an embryo's susceptibility to certain diseases.